Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias

Haematologica

Volumn 83, Issue 10, 1998, Pages 904-909

  Carella, Angelo M ^a   Lerma, Enrica ^a   Dejana, Anna ^a   Corsetti, Maria T ^a   Celesti, Lidia ^a   Bruni, Roberta ^a   Benvenuto, Federica ^a   Figari, Osvaldo ^a   Parodi, Caterina ^b   Carlier, Paolo ^a   Florio, Gaetano ^a   Lercari, Giuseppe ^a   Valbonesi, Mauro ^c   Casarino, Lucia ^d   De Stefano, Francesco ^d   Geniram, Adriana ^e   Venturino, Marco ^e   Tedeschi, Lucilla ^e   Palmieri, Giovannella ^f   Piaggio, Giovanna ^a   Podestà, Marina ^a   Frassoni, Francesco ^a   Van Lint, Maria Teresa ^g   Marmont, Alberto M ^a   Bacigalupo, Andrea ^a   more..

^a UNIVERSITY OF GENOA   (Italy)

^b Cytogenetics   (Italy)

^c Blood Centre   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e SAN CARLO BORROMEO HOSPITAL   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g NONE

Author keywords

Allografting; Autografting; High dose chemotherapy; Immunosuppressive therapy; Mobilization therapy

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; MELPHALAN; METHOTREXATE; MITOXANTRONE;

ADULT; ARTICLE; AUTOGRAFT; BLOOD DISEASE; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; POSTOPERATIVE COMPLICATION; REFRACTORY ANEMIA; TREATMENT OUTCOME;

ADULT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031791706     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft versus leukemia without myeloablative therapy. Blood 1997; 89:4531-6.
2. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91:756-53.
3. Carella AM, Cunningham I, Lerma E, et al. Mobilization and transplantation of Philadelphia-negative peripheral blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 1997;15:1575-82.
4. Carella AM, Lerma E, Celesti L, et al. Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen. Br J Haematol 1998; 100:445-8.
5. Chopra R, McMillan AK, Linch DC. The place of high-dose BEAM therapy and ABMT in poor-prognosis Hodgkin's disease: a single-center eight-year study of 155 patients. Blood 1993; 81:1137-45.
6. Priebe T, Platsoucas CD, Seiki H, Fox FE, Nelson JA. Purine nucleoside modulation of function of human lymphocytes. Cell Immunol 1990; 129:321-6.
7. Seymour JF, Khouri IF, Champlin RE, Keating MJ. Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Am J Clin Oncol 1994; 17:360-7.
8. Mehta J, Powles R, Singhal S, et al. T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure. Bone Marrow Transplant 1996; 17:881-5.
9. Wijermans PW, Gerrits WB, Haak HL, et al. Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol 1993; 50:292-6.